It may take Haffkine 12 months to start producing Covaxin SECTIONS Share Synopsis “Any vaccine is a biological product and has to be produced with the utmost precaution of biosafety,” Sandeep Rathod, CEO of Haffkine Bio-Pharmaceutical, told ET. “This is coronavirus and they require BSL-111 facility and they need to have negative pressure facility, which means the virus — even if leaked — does not leave the facility.” ET Bureau Haffkine Bio-Pharmaceutical Corporation will take at least 12 months to start manufacturing Bharat Biotech’s Covaxin vaccine because the company will need time to set up safe production facilities. “Any vaccine is a biological product and has to be produced with the utmost precaution of biosafety,” Sandeep Rathod, CEO of Haffkine Bio-Pharmaceutical, told ET. “This is coronavirus and they require BSL-111 facility and they need to have negative pressure facility, which means the virus — even if leaked — does not leave the facility.”